Children and young people with common mental health disorders and epilepsy Mental and Behavioural Disorders
Conditions
Interventions
Participants will be randomised to one of two treatment groups. Half of the participants will receive MATCH-ADTC in addition to usual care, and half of the participants will be receive usual care alon
Sponsors
Great Ormond Street Hospital for Children NHS Foundation Trust
Eligibility
Sex/Gender
All
Age
3 Years to 18 Years
Inclusion criteria
Inclusion criteria: 1. Attending clinics for the treatment of epilepsy 2. Aged 3-18 years 3. Meeting DSM-5 diagnostic criteria for a mental health disorder (e.g. depression, anxiety, disruptive behaviour or trauma) identified by the SDQ, DAWBA and clinical assessment 4. Have a parent/carer who is also willing to take part in the study
Exclusion criteria
Exclusion criteria: 1. Not speaking/understanding English sufficiently well to access the screening assessments 2. Having an intellectual disability at a level meaning that they cannot access the measures and/or intervention 3. Screening results that indicate a severe mental health disorder not considered suitable for the trial intervention 4. Actively receiving intensive psychological input focused on cognitive and/or behavioural strategies to intervene with emotional or behavioural difficulties at the time of the assessment or due to have such input during the study period 5. Refusing to consent to the research team contacting their GP/other relevant health professionals about their inclusion in the research 6. Refusing to have the trial therapy sessions audio and/or video recorded 7. Aged 16+ and unable to consent for themselves 8. Unable to complete the measures despite all reasonable efforts being made to assist
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Total difficulties score from the Strengths and Difficulties Questionnaire reported by the parent/carer measured at baseline, 6 months and 12 months | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. Mental health diagnosis according to the Development and Wellbeing Assessment (DAWBA) measured at baseline, 6 months and 12 months. 2. Anxiety and depression measured by the Revised Children’s Anxiety and Depression Scale (RCADS) measured at baseline, 6 months and 12 months. 3. Number and severity of adverse events measured at baseline, 6 months and 12 months. 4. Seizure severity measured by the Hague Seizure Severity Scale measured at baseline, 6 months and 12 months. 5. Quality of life measured by the EuroQol 5-dimensions measures, five-level version (EQ-5D-5L) measured at baseline, 6 months and 12 months. 6. Quality of life measured by the Paediatric Quality of Life measures (PedsQL) – Epilepsy Module measured at baseline, 6 months and 12 months. 7. Service use measured by the Child and Adolescent Service Use Schedule (CA-SUS) measured at baseline, 6 months and 12 months. 8. Health utility measured by the Child Health Utility 9-dimensions (CHU-9D) measured at baseline, 6 months and 12 months. 9. Intelligence measured by the Peabody Picture Vocabulary Test (PPVT) at baseline 10. School attendance (self-reported) measured at baseline, 6 months and 12 months. 11. School performance (self-reported) measured at baseline, 6 months and 12 months. 12. Session-by-session measures (e.g. goal based outcomes) measured at baseline and after each therapy session. 13. Measures allowing for therapist self-rating of competence in delivering treatment and adherence to the treatment manual measured at baseline and after therapy is completed | — |
Countries
England, United Kingdom
Contacts
Public ContactRoz Shafran
Outcome results
None listed